<Disease><Name>PSEUDO ZELLWEGER -&gt; D-BIFUNCTIONAL PROTEIN DEFICIENCY</Name><Synonym>DBP DEFICIENCY</Synonym><OMIM><Number>261515</Number><URL>http://omim.org/entry/261515</URL></OMIM><Orphanet><Number>300</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=300</URL></Orphanet><Protein><Number>Peroxisomal multifunctional enzyme type 2</Number><URL>http://www.uniprot.org/uniprot/P51659</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>5q23.1</Gene><ICD>E71.3</ICD><Summary>very rare;autosomal recessive ;mutation in the HSD17B4 gene;the reported biochemical aberrations can no longer be explained by a deficiency of this thiolase ... the true defect in this patient is at the level of d-bifunctional protein (DBP) [Ferdinandusse S et al. 2002]</Summary><Symptoms><symtomp><id>2227</id><symptom>dysmorphism / dysmorphic features</symptom><category>HEAD</category></symtomp><symtomp><id>2423</id><symptom>early death</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1917</id><symptom>neurological deterioration / neurologic deterioration</symptom><category>GENERAL TOPICS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2122</id><symptom>renal cysts</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>433</id><name>Pipecolic acid</name><specimen>urine</specimen><value /><min>0.50</min><max>35.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method>GCMS</method><comment /></metabolite><metabolite><id>435</id><name>Pipecolic acid</name><specimen>urine</specimen><value /><min>0.10</min><max>3.50</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>GCMS</method><comment /></metabolite><metabolite><id>2036</id><name>Pipecolic acid</name><specimen>urine</specimen><value /><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>428</id><name>Pipecolic acid</name><specimen>plasma</specimen><value>increased</value><min>0.80</min><max>5.30</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>429</id><name>Pipecolic acid</name><specimen>plasma</specimen><value>increased</value><min>0.50</min><max>3.80</max><unit>&#181;mol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>430</id><name>Pipecolic acid</name><specimen>plasma</specimen><value>increased</value><min>0.40</min><max>4.90</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>431</id><name>Pipecolic acid</name><specimen>plasma</specimen><value>increased</value><min>0.70</min><max>2.60</max><unit>&#181;mol/l</unit><age>&gt;5 years</age><method /><comment /></metabolite><metabolite><id>432</id><name>Pipecolic acid</name><specimen>urine</specimen><value>increased</value><min>13.90</min><max>44.70</max><unit>&#181;mol/g creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>434</id><name>Pipecolic acid</name><specimen>urine</specimen><value>increased</value><min>1.60</min><max>13.40</max><unit>&#181;mol/g creatinine</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>1302</id><title>Reinvestigation of peroxisomal 3-ketoacyl-CoA thiolase deficiency: identification of the true defect at the level of d-bifuncti</title><author>Ferdinandusse S</author><journal>Am J Hum Genet</journal><year>2002</year><book /><volume>70</volume><number>6</number><pages>1589-1593</pages><co_aut>et al.</co_aut></literature><literature><id>982</id><title>Plasma very long chain fatty acids in 3000 peroxisome disease patients and 29000 controls</title><author>Moser AB</author><journal>Ann Neurol</journal><year>1999</year><book /><volume>45</volume><number>1</number><pages>100-110</pages><co_aut>et al.</co_aut></literature><literature><id>229</id><title>Peroxisomal disorders</title><author>Heymans HS</author><journal>J Inherit Metab Dis</journal><year>1995</year><book /><volume>0</volume><number>0</number><pages>421-433</pages><co_aut>Wanders RJA, Schutgens RBH</co_aut></literature><literature><id>232</id><title>Clinical approach to inherited peroxisomal disorders</title><author>Poggi-Travert F</author><journal>J Inher Met Dis Suppl</journal><year>1995</year><book /><volume>18</volume><number>0</number><pages>1-18</pages><co_aut>et al.</co_aut></literature><literature><id>52</id><title>Pseudo-Zellweger syndrome: deficiencies in several peroxisomal oxidative activities</title><author>Goldfischer S</author><journal>J Pediatr</journal><year>1986</year><book /><volume>108</volume><number>0</number><pages>25-32</pages><co_aut>Collins J, Rapin I, Neumann P, Neglia W, Spiro AJ, Ishii T, Roels F, Vamecq J, van Hoof F</co_aut></literature></Literatures></Disease>